Form 4 Tracker
ROCKET PHARMACEUTICALS, INC.
RCKT

31 insider filings · Latest: Aug 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 11, 2026Aug 13 8:15 PMChristopher James StevensChief Operating Officer
Sale
36,658$3.50$128.3K505,784(D)

View →

Aug 11, 2026Aug 13 8:15 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Sale
4,701$3.50$16.4K262,809(D)

View →

Aug 13, 2026Aug 13 8:03 PMWilson Martin
Proposed Sale
3,493$3.38$11.8K

View →

Aug 13, 2026Aug 13 7:39 PMShah Gaurav
Proposed Sale
2,837$3.38$9.6K

View →

Aug 11, 2026Aug 11 7:30 PMStevens Christopher James
Proposed Sale
36,658$3.50$128.3K

View →

Aug 11, 2026Aug 11 7:23 PMChaudhuri Sarbani
Proposed Sale
4,701$3.50$16.5K

View →

Jul 7, 2026Jul 7 7:13 PMMalik Fady Ibraham
Proposed Sale
10,670$3.88$41.4K

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Sale
55,684$3.09$171.8K1,061,724(D)

View →

May 19, 2026May 21 8:06 PMGaurav ShahCEO
Sale
2,409$3.01$7.3K1,040,918(D)

View →

May 19, 2026May 21 8:06 PMMartin WilsonGeneral Counsel
Sale
662$3.01$2.0K677,977(D)

View →

May 19, 2026May 21 8:06 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
384$3.01$1.2K89,780(D)

View →

May 21, 2026May 21 7:40 PMShah Gaurav
Proposed Sale
55,684$3.09$171.8K

View →

May 19, 2026May 19 7:38 PMShah Gaurav
Proposed Sale
2,409$3.01$7.3K

View →

May 19, 2026May 19 7:33 PMMilitello John
Proposed Sale
384$3.01$1.2K

View →

May 19, 2026May 19 7:20 PMWilson Martin
Proposed Sale
662$3.01$2.0K

View →

May 13, 2026May 14 8:22 PMMartin WilsonGeneral Counsel
Sale
3,361$3.61$12.1K678,639(D)

View →

May 13, 2026May 14 8:19 PMGaurav ShahCEO
Sale
2,728$3.61$9.8K1,043,327(D)

View →

May 13, 2026May 14 8:16 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
855$3.61$3.1K90,164(D)

View →

May 13, 2026May 13 7:15 PMWilson Martin
Proposed Sale
3,361$3.61$12.1K

View →

May 13, 2026May 13 7:13 PMShah Gaurav
Proposed Sale
2,728$3.61$9.8K

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 3, 2026Aug 6 12:49 AMChristopher James StevensChief Operating Officer
Grant/Award
101,428$3.41101,428(D)

View →

Jun 18, 2026Jul 7 12:00 AMRoderick WongDirector, 10% Owner
Grant/Award
78,960$3.3578,960(D)

View →

Jun 18, 2026Jul 7 12:00 AMPeter FongDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMMikael DolstenDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMFady Ibraham MalikDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMDavid P SouthwellDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMCarsten BoessDirector
Grant/Award
64,860$3.3564,860(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Disposition
238,256$62.320(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Grant/Award
116,562$3.009,091(D)

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Option Exercise
76,490$1.690(D)

View →

Feb 11, 2026Feb 13 9:05 PMGaurav ShahCEO
Grant/Award
870,648$3.24870,648(D)

View →

Feb 11, 2026Feb 13 9:05 PMJohn MilitelloOfficer
Grant/Award
45,018$3.2445,018(D)

View →

Feb 11, 2026Feb 13 9:05 PMMartin WilsonGeneral Counsel
Grant/Award
468,187$3.24468,187(D)

View →

Feb 11, 2026Feb 13 9:05 PMSyed Ali-Aamir RizviChief Medical Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMChristopher James StevensChief Operating Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Grant/Award
189,076$3.24189,076(D)

View →